Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors

Science

Volumn 264, Issue 5163, 1994, Pages 1319-1322

  Novogrodsky, Abraham ^a   Vanichkin, Alexey ^a   Patya, Miriam ^a   Gazit, Aviv ^b   Osherov, Nir ^b   Levitzki, Alexander ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; TUMOR NECROSIS FACTOR ALPHA; TYRPHOSTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SEPTIC SHOCK;

EID: 0028343059     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.8191285     Document Type: Article

References (43)

1. J. E. Parillo, N. Engl. J. Med. 328, 1471 (1993).
2. E. J. Ziegler, ibid 307, 1225 (1982); R. L. Greenman et al., J. Am. Med. Assoc 266, 1097 (1991).
3. E. J. Ziegler, ibid 307, 1225 (1982); R. L. Greenman et al., J. Am. Med. Assoc 266, 1097 (1991).
4. C. A. Geunter, V. Florica, B. J. Hinshaw, J. Appl. Physiol. 26, 780 (1969); C. R. Raetz, Annu. Rev. Biochem. 59, 124 (1990).
5. C. A. Geunter, V. Florica, B. J. Hinshaw, J. Appl. Physiol. 26, 780 (1969); C. R. Raetz, Annu. Rev. Biochem. 59, 124 (1990).
6. B. Beutler and A. Cerami, Annu. Rev. Biochem. 57, 505 (1988).
7. A. H. Ding et al., J. Immunol. 141, 2407 (1988); X. Zang and D. C. Morrison, J. Exp. Med. 177, 511 (1993).
8. A. H. Ding et al., J. Immunol. 141, 2407 (1988); X. Zang and D. C. Morrison, J. Exp. Med. 177, 511 (1993).
9. S. Okusawa et al., J. Clin. Invest. 81, 1162 (1988); B. Everaedt, P. Broukaet, A. Shaw, W. Fiers, Biochem. Biophys. Res. Commun. 163, 378 (1989).
10. S. Okusawa et al., J. Clin. Invest. 81, 1162 (1988); B. Everaedt, P. Broukaet, A. Shaw, W. Fiers, Biochem. Biophys. Res. Commun. 163, 378 (1989).
11. K. Pfeffer et al. Cell 73, 457 (1993); J. Rothe et al., Nature 364, 798 (1993).
12. K. Pfeffer et al. Cell 73, 457 (1993); J. Rothe et al., Nature 364, 798 (1993).
13. B. Beutler, I. W. Milsark, A. C. Cerami, Science 229, 869 (1985).
14. K. Ohlsson et al., Nature 348, 550 (1990).
15. S. L. Weinstein, M. R. Gold, A. L. DeFranco, Proc. Natl. Acad. Sci. U.S.A. 88, 4148 (1991).
16. K. B. Glaser et al., Biochem. Pharmacol. 45, 711 (1993).
17. Z. Dong, C. A. O'Brien, I. J. Fidler, J. Leukocyte Biol. 53, 53 (1993).
18. M. Kohmo et al., Biochem. J. 267, 91 (1990); A. V. Hoffbrand and R. G. Wickremasinghe, Blood 75, 88 (1990); I. Victor et al., J. Biol. Chem. 268, 18994 (1993).
19. M. Kohmo et al., Biochem. J. 267, 91 (1990); A. V. Hoffbrand and R. G. Wickremasinghe, Blood 75, 88 (1990); I. Victor et al., J. Biol. Chem. 268, 18994 (1993).
20. M. Kohmo et al., Biochem. J. 267, 91 (1990); A. V. Hoffbrand and R. G. Wickremasinghe, Blood 75, 88 (1990); I. Victor et al., J. Biol. Chem. 268, 18994 (1993).
21. E. Munoz et al., Eur. J. Immunol. 22, 1391 (1992); G. R. Guy et al., J. Biol. Chem. 266, 14343 (1991).
22. E. Munoz et al., Eur. J. Immunol. 22, 1391 (1992); G. R. Guy et al., J. Biol. Chem. 266, 14343 (1991).
23. P. Yaish, A. Gazit, C. Gilon, A. Levitzki, Science 242, 933 (1988); A. Levitzki, FASEB J. 6, 3275 (1992).
24. P. Yaish, A. Gazit, C. Gilon, A. Levitzki, Science 242, 933 (1988); A. Levitzki, FASEB J. 6, 3275 (1992).
25. T. Iwasaki et al., FEBS Lett. 298, 240 (1992).
26. D. W. Coyne and A. R. Morrison, Biochem. Biophys. Res. Commun. 173, 718 (1990).
27. I. Stefanova et al., J. Biol. Chem. 268, 20725 (1993).
28. R. G. Kilbourn et al., Proc. Natl. Acad. Sci. U.S.A. 87, 3629 (1990); R. G. Kilbourn and O. W. Griffith, J. Natl. Cancer Inst. 84, 827 (1992).
29. R. G. Kilbourn et al., Proc. Natl. Acad. Sci. U.S.A. 87, 3629 (1990); R. G. Kilbourn and O. W. Griffith, J. Natl. Cancer Inst. 84, 827 (1992).
30. Z. Dong et al., J. Immunol. 151, 2717 (1993); N. Marczin et al., Am. J. Physiol. 265, H110 (1993).
31. Z. Dong et al., J. Immunol. 151, 2717 (1993); N. Marczin et al., Am. J. Physiol. 265, H110 (1993).
32. F. Bohmer et al., unpublished results; A. Gazit et al., J. Med. Chem. 32, 2344 (1989); unpublished experiments.
33. F. Bohmer et al., unpublished results; A. Gazit et al., J. Med. Chem. 32, 2344 (1989); unpublished experiments.
34. 2. Nonadherent cells were removed, and complete medium (RPMI 1640 containing heat-inactivated newborn calf serum) was added. After incubation of macrophage monolayers for 20 hours, tyrphostins were added at a final concentration of 20 μM followed 2 hours later by the addition of E. coli 055:B5 LPS (10 μg/ml). Endotoxin (Sigma) was prepared by phenol extraction. After incubation for 6 hours, supernatants were collected and the concentration of TNF-α was determined with an ELISA kit (Endogen). The results are expressed as the mean of two determinators; deviations from the mean did not exceed 8%.
35. - production seems to depend on the method of macrophage preparation, whereas maximal LPS does not depend on the preparation.
36. D. Wallach et al., J. Immunol. 140, 2994 (1988).
37. The tyrphostins AG 490 and AG 556 were found to be more active in inhibiting TNF-α cytotoxicity in vitro (two- to threefold). This finding suggests that different sets of PTKs mediate the effects of LPS and TNF-α and, therefore, that different families of tyrphostins will be effective against these two agents.
38. S. L. Weinstein et al., J. Biol. Chem. 267, 14955 (1993); Z. Dong et al., J. Exp. Med. 177, 1071 (1993).
39. S. L. Weinstein et al., J. Biol. Chem. 267, 14955 (1993); Z. Dong et al., J. Exp. Med. 177, 1071 (1993).
40. D. G. Remick et al., Lab. Invest. 60, 766 (1989).
41. M. Gadina et al., J. Exp. Med. 173, 1305 (1991).
42. 6 U/mg (Reportech, Rocky Hill, NJ) at 0.0, 0.2, and 0.5 ng/ml with and without 10 μM tyrphostin. After incubation for 18 hours, the supernatants were aspirated, the monolayers were washed twice with PBS, and 200 μl of neutral red solution (0.02%) was added. After incubation for 2 hours, cells were washed out and the dye that had been absorbed by the live cells was extracted upon the addition of 200 μl of Sorenson buffer containing 50% ethanol. The concentration of the dye was determined by an ELISA autoreader with a 550-nm filter.
43. We thank M. Collazo from SUGEN, Inc. (Redwood City, CA) for helping in the preparation of this manuscript.